Among the 21 selected CTAs, GAGE2, CT45, CCT4, and PRAME cancer/testis antigens were revealed to be correlated with the prognosis for ovarian cancer patients, and GAGE2, CCT4, and PRAME were identified for the first time. Here, PRAME is linked to ovarian cancer.